|
Originally published In Press as doi:10.1074/jbc.M103788200 on June 7, 2001
J. Biol. Chem., Vol. 276, Issue 32, 30335-30341, August 10, 2001
Early Intermediates in HIV-1 Envelope
Glycoprotein-mediated Fusion Triggered by CD4 and Co-receptor
Complexes*
Antony S.
Dimitrov,
Xiaodong
Xiao,
Dimiter S.
Dimitrov, and
Robert
Blumenthal
From the Laboratory of Experimental and Computational Biology,
Center for Cancer Research, NCI, National Institutes of Health,
Frederick, Maryland 21702
An early step in the process of HIV-1
entry into target cells is the activation of its envelope glycoprotein
(GP120-GP41) to a fusogenic state upon binding to target cell CD4 and
cognate co-receptor. Incubation of human immunodeficiency virus (HIV)-1 Env-expressing cells with an excess of CD4 and co-recepeptor-bearing target cells resulted in an influx of an impermeant nucleic
acid-staining fluorescent dye into the Env-expressing cells. The dye
influx occurred concomitant with cell fusion. No influx of dye into
target cells was observed if they were incubated with an excess of
Env-expressing cells. The permeabilization of Env-expressing cells was
also triggered by CD4·co-receptor complexes attached to Protein
G-Sepharose beads in the absence of target cells. The CD4 and
co-receptor-induced permeabilization of Env-expressing cells occurred
with the same specificity with respect to co-receptor usage as cell
fusion. Natural ligands for the co-receptors and C-terminal GP41
peptide inhibitors of HIV-1 fusion blocked this effect. Our results
indicate that the process of HIV-1 Env-mediated fusion is initiated by the destabilization of HIV-1 Env-expressing membranes.
Further elucidation of these early intermediates may help identify and develop potential inhibitors of HIV-1 entry into cells.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Center for Cancer
Research, P.O. Box B, Bldg. 469, Rm. 216A, Miller Dr., Frederick, MD
21702-1201. Tel.: 301-846-1446; Fax: 301-846-6192; E-mail: blumen@helix.nih.gov.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. J. Chang, F. Wightman, A. Bartholomeusz, A. Ayres, S. J. Kent, J. Sasadeusz, and S. R. Lewin
Reduced Hepatitis B Virus (HBV)-Specific CD4+ T-Cell Responses in Human Immunodeficiency Virus Type 1-HBV-Coinfected Individuals Receiving HBV-Active Antiretroviral Therapy
J. Virol.,
March 1, 2005;
79(5):
3038 - 3051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Daecke, O. T. Fackler, M. T. Dittmar, and H.-G. Krausslich
Involvement of Clathrin-Mediated Endocytosis in Human Immunodeficiency Virus Type 1 Entry
J. Virol.,
February 1, 2005;
79(3):
1581 - 1594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Koshiba and D. C. Chan
The Prefusogenic Intermediate of HIV-1 gp41 Contains Exposed C-peptide Regions
J. Biol. Chem.,
February 21, 2003;
278(9):
7573 - 7579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Saez-Cirion, S. Nir, M. Lorizate, A. Agirre, A. Cruz, J. Perez-Gil, and J. L. Nieva
Sphingomyelin and Cholesterol Promote HIV-1 gp41 Pretransmembrane Sequence Surface Aggregation and Membrane Restructuring
J. Biol. Chem.,
June 7, 2002;
277(24):
21776 - 21785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Moulard, S. K. Phogat, Y. Shu, A. F. Labrijn, X. Xiao, J. M. Binley, M.-Y. Zhang, I. A. Sidorov, C. C. Broder, J. Robinson, et al.
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes
PNAS,
May 14, 2002;
99(10):
6913 - 6918.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|